Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Mesothelioma, Malignant × abemaciclib × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Breast Neoplasms 27 Endometrial Neoplasms 6 Neoplasms 5 Neoplasm Metastasis 5 Triple Negative Breast Neoplasms 4 Ovarian Neoplasms 4 Prostatic Neoplasms 3 Meningioma 3 Head and Neck Neoplasms 3 Glioblastoma 3 Brain Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Pancreatic Neoplasms 2 Oligodendroglioma 2 Lymphoma, Non-Hodgkin 2 Urologic Neoplasms 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Retinoblastoma 1 Recurrence 1 Pathologic Complete Response 1 Osteosarcoma 1 Neoplasms, Squamous Cell 1 Neoplasm, Residual 1 Multiple Myeloma 1 Metastatic Castration-Resistant Prostate Cancer 1 Mesothelioma, Malignant 1

Interventions

Cisplatin 26 Pemetrexed 21 Gemcitabine 9 Nivolumab 8 Carboplatin 8 pembrolizumab 7 tremelimumab 5 durvalumab 5 atezolizumab 5 Radiotherapy 4 Chemotherapy, Adjuvant 4 Vinorelbine 3 Ipilimumab 3 Doxorubicin 3 Bevacizumab 3 tumor necrosis factor-alpha, CNGRC fusion protein, human 2 sodium thiosulfate 2 sargramostim 2 niraparib 2 nintedanib 2 liposomal doxorubicin 2 lenvatinib 2 defactinib 2 cemiplimab 2 amatuximab 2 Trabectedin 2 Neoadjuvant Therapy 2 Mitomycin 2 Methotrexate 2 Interferon-gamma 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03654833 2023-03-14

MiST

University of Leicester

Phase 2 Unknown

Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡